Gw Pharma

Developer of cannabinoid medicines for MS spasticity, cancer pain and childhood epilepsy

placeCambridge, England, United Kingdom calendar_todayFounded 1998 groups326 employees language gwpharm.com

Registered entities

Innovation

96 patent families (74 granted) — focus: Human necessities, Operations & transport, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 10,902 times.

YearFilings
201439
201534
201631
201733
201826
201921
202024
202115
202210
20238
20247
20251

Investor mix

8 investors on record.

Investor typeCountShare
Venture capital338%
Private equity338%
Bank & private debt113%
Other / undisclosed113%
Coming soon